Anti-Inflammatory Effects Of A Mytilus Coruscus Alpha-D-Glucan (Mp-A) In Activated Macrophage Cells Via Tlr4/Nf-Kappa B/Mapk Pathway Inhibition
Fuyan Liu,Xiaofeng Zhang,Yuqiu Li,Qixin Chen,Fei Liu,Xiqiang Zhu,Li Mei,Xinlei Song,Xia Liu,Zhigang Song,Jinhua Zhang,Wen Zhang,Peixue Ling,Fengshan Wang
DOI: https://doi.org/10.3390/md15090294
2017-01-01
Marine Drugs
Abstract:The hard-shelled mussel (Mytilus coruscus) has been used as Chinese traditional medicine for thousands of years; however, to date the ingredients responsible for the various beneficial health outcomes attributed to Mytilus coruscus are still unclear. An alpha-D-Glucan, called MP-A, was isolated from Mytilus coruscus, and observed to exert anti-inflammatory activity in THP-1 human macrophage cells. Specifically, we showed that MP-A treatment inhibited the production of inflammatory markers, including TNF-alpha, NO, and PGE2, inducible NOS (iNOS), and cyclooxygenase-2 (COX-2), in LPS-activated THP-1 cells. It was also shown to enhance phagocytosis in the analyzed cells, but to severely inhibit the phosphorylation of mitogen-activated protein kinases (MAPKs) and the nuclear translocation of NF-kappa B P65. Finally, MP-A was found to exhibit a high binding affinity for the cell surface receptor TLR4, but a low affinity for TLR2 and dectin-1, via surface plasmon resonance (SPR) analysis. The study indicates that MP-A suppresses LPS-induced TNF-alpha, NO and PEG2 production via TLR4/NF-kappa B/MAPK pathway inhibition, and suggests that MP-A may be a promising therapeutic candidate for diseases associated with TNF-alpha, NO, and/or PEG2 overproduction.